Addison Advisors’s Idexx Laboratories IDXX Stock Holding History

Addison Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.37K	Sell	14 -762	-98%	-$427K	﹤0.01%	448
2026 Q1	$436K	Buy	776 +3	+0.4%	+$1.92K	0.1%	140
2025 Q4	$523K	Buy	773 +2	+0.3%	+$1.36K	0.12%	125
2025 Q3	$493K	Sell	771 -19	-2%	-$11.5K	0.11%	127
2025 Q2	$424K	Sell	790 -23	-3%	-$11K	0.11%	137
2025 Q1	$341K	Sell	813 -16	-2%	-$6.95K	0.09%	143
2024 Q4	$343K	Buy	829 +21	+3%	+$9.21K	0.1%	136
2024 Q3	$408K	Buy	808 +5	+0.6%	+$2.43K	0.11%	129
2024 Q2	$391K	Sell	803 -35	-4%	-$17.6K	0.13%	124
2024 Q1	$452K	Hold	838	–	–	0.16%	110
2023 Q4	$465K	Hold	838	–	–	0.18%	91
2023 Q3	$366K	Sell	838 -160	-16%	-$79.8K	0.17%	102
2023 Q2	$501K	Buy	998 +80	+9%	+$38.3K	0.25%	77
2023 Q1	$459K	Sell	918 -40	-4%	-$19.1K	0.26%	78
2022 Q4	$391K	Sell	958 -313	-25%	-$121K	0.23%	88
2022 Q3	$414K	Hold	1,271	–	–	0.26%	76
2022 Q2	$446K	Hold	1,271	–	–	0.27%	74
2022 Q1	$695K	Buy	1,271 +274	+27%	+$144K	0.38%	61
2021 Q4	$656K	Buy	+997	New	+$626K	0.41%	50

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Addison Advisors's IDXX Position: Q2 2026 in Review

Addison Advisors reduced its Idexx Laboratories (IDXX) stake by 98% in Q2 2026, selling an estimated $427K and leaving 14 shares worth $7.37K. The position accounts for ﹤0.01% of the portfolio, ranked #448.

Addison Advisors first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $695K in Q1 2022. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Addison Advisors held 14 shares of Idexx Laboratories worth $7.37K as of Q2 2026.
Addison Advisors sold 762 Idexx Laboratories shares in Q2 2026, an estimated $427K.
Idexx Laboratories made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #448 holding.
Addison Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
Addison Advisors's Idexx Laboratories position peaked at $695K in Q1 2022.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.